Cardiff Oncology (CRDF) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $1.00 +2.04%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Cardiff Oncology (NASDAQ: CRDF) to $13.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
